GR3005660T3 - - Google Patents

Info

Publication number
GR3005660T3
GR3005660T3 GR920401983T GR920401983T GR3005660T3 GR 3005660 T3 GR3005660 T3 GR 3005660T3 GR 920401983 T GR920401983 T GR 920401983T GR 920401983 T GR920401983 T GR 920401983T GR 3005660 T3 GR3005660 T3 GR 3005660T3
Authority
GR
Greece
Application number
GR920401983T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868615669A external-priority patent/GB8615669D0/en
Priority claimed from GB868629641A external-priority patent/GB8629641D0/en
Application filed filed Critical
Publication of GR3005660T3 publication Critical patent/GR3005660T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR920401983T 1986-06-26 1992-09-10 GR3005660T3 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868615669A GB8615669D0 (en) 1986-06-26 1986-06-26 Treatment
GB868629641A GB8629641D0 (en) 1986-12-11 1986-12-11 Treatment

Publications (1)

Publication Number Publication Date
GR3005660T3 true GR3005660T3 (enExample) 1993-06-07

Family

ID=26290960

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401983T GR3005660T3 (enExample) 1986-06-26 1992-09-10

Country Status (8)

Country Link
US (1) US4790989A (enExample)
EP (1) EP0251434B1 (enExample)
AU (1) AU600264B2 (enExample)
DE (1) DE3780091T2 (enExample)
DK (1) DK186087A (enExample)
ES (1) ES2041681T3 (enExample)
GR (1) GR3005660T3 (enExample)
IE (1) IE59628B1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
US5279830A (en) * 1990-04-16 1994-01-18 Intellectual Property Holding Co. Mineral oil free and lanolin free cosmetic composition
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors
GB9026873D0 (en) * 1990-12-11 1991-01-30 Beecham Group Plc Novel compounds
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
ES2157996T3 (es) * 1993-10-22 2001-09-01 Smithkline Beecham Corp Nueva composicion.
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
IL129237A0 (en) * 1996-10-01 2000-02-17 Smithkline Beecham Corp Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
CA2299298A1 (en) * 1997-08-09 1999-02-18 Jane Elizabeth Hilton Compositions for nasal administration
CA2303443A1 (en) * 1997-09-11 1999-03-18 Anthony Guy Hatton Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
PL358615A1 (en) * 1999-02-03 2004-08-09 Biogal Gyogyszergyar Rt Process for the preparation of pseudomonic acid a antibiotic by microbiological method
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
CZ200467A3 (cs) 2001-06-21 2004-10-13 Biogalágyogyszergyarárt Metabolicky řízený způsob fermentace pro výrobu pseudomonové kyseliny
EP1455769A4 (en) 2001-12-28 2004-09-22 Biogal Gyogyszergyar METHOD FOR PRODUCING CRYSTALLINE AND AMORPHIC MUPIROCIN CALCIUM
EP1619947A4 (en) * 2003-05-01 2006-05-31 Replidyne Inc ANTIBACTERIAL COMPOSITIONS AND ASSOCIATED METHODS
US20050123576A1 (en) * 2003-12-03 2005-06-09 Ilana Lavon Mupirocin compositions for topical use, an improved process of making same and methods of using same
DE602005019509D1 (de) 2004-06-01 2010-04-08 Teva Gyogyszergyar Zartkoeruen Verfahren für die zubereitung der amorphen form eines medikamentes
EP2444067A1 (en) 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Anhydrous gel comprising mupirocin
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
GB2544395B (en) * 2015-09-25 2019-05-22 Mitsubishi Materials Corp Method for regenerating precious metal clay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837322A (en) * 1973-07-30 1974-09-24 Honda Motor Co Ltd Carburetor choke
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8428952D0 (en) * 1984-11-16 1984-12-27 Beecham Group Plc Formulations

Also Published As

Publication number Publication date
DK186087A (da) 1987-12-27
EP0251434A3 (en) 1988-02-24
EP0251434B1 (en) 1992-07-01
DE3780091T2 (de) 1993-02-11
AU7132987A (en) 1988-01-07
DE3780091D1 (de) 1992-08-06
US4790989A (en) 1988-12-13
IE870889L (en) 1987-12-26
EP0251434A2 (en) 1988-01-07
DK186087D0 (da) 1987-04-10
ES2041681T3 (es) 1993-12-01
AU600264B2 (en) 1990-08-09
IE59628B1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
IN168664B (enExample)
GR3005660T3 (enExample)
IN164853B (enExample)
GR3006907T3 (enExample)
DE3790760T1 (enExample)
IN170739B (enExample)
JPH0662563B1 (enExample)
GR3004369T3 (enExample)
GR3006612T3 (enExample)
DE3777286D1 (enExample)
IN173793B (enExample)
GB8620171D0 (enExample)
IN172283B (enExample)
AU5783386A (enExample)
AU6053586A (enExample)
AU5767086A (enExample)
AU5348186A (enExample)
AU6161186A (enExample)
AU5724586A (enExample)
AU5703286A (enExample)
IT8603447A1 (it) Apparecchiatura per congiungere al nastro di una bobina in esaurimento il lembo iniziale di una nuova bobina.
AU5684886A (enExample)
AU5857886A (enExample)
AU5878886A (enExample)
AU5655786A (enExample)